Novel therapeutic concepts for inflammatory bowel disease-from bench to bedside

J Mol Med (Berl). 2017 Sep;95(9):899-903. doi: 10.1007/s00109-017-1574-9.

Authors

Viola Neudecker¹, Sean P Colgan², Holger K Eltzschig³

Affiliations

¹ Department of Anesthesiology, University Hospital, LMU Munich, Munich, Germany. viola.neudecker@med.uni-muenchen.de.
² Department of Medicine and the Mucosal Inflammation Program, University of Colorado Denver, Aurora, CO, USA.
³ Department of Anesthesiology, The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX, USA.

No abstract available

Publication types

Editorial
Introductory Journal Article
Research Support, N.I.H., Extramural

MeSH terms

Adenosine / metabolism
Humans
Hypoxia-Inducible Factor 1 / metabolism
Immunity, Mucosal
Inflammatory Bowel Diseases / genetics
Inflammatory Bowel Diseases / immunology
Inflammatory Bowel Diseases / metabolism
Inflammatory Bowel Diseases / therapy*
Intestinal Mucosa / immunology
Intestinal Mucosa / metabolism
MicroRNAs

Substances

Hypoxia-Inducible Factor 1
MicroRNAs
Adenosine

Grants and funding